Denali Therapeutics (NASDAQ:DNLI) founder and CEO Ryan Watts said 2026 is shaping up to be a pivotal year for the company as it approaches a potential first product approval and advances multiple ...
Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...
From cancer to Alzheimer’s: could a renewed focus on energy transform biomedicine? Including energy dynamics in research could improve our understanding of diseases and of the healing processes that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results